Reuters Health Report

If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE

Good Morning Pan, MON 15 Nov 2010    StemCells plans chronic spinal cord injury trial Fast heart rate, rhythm problems found in bereaved Less salt for teens means healthier adults Haiti cholera toll tops 900 with six provinces affected Pfizer heart-failure drug helps milder patients: study Bypass patients can benefit from a few drinks: study Medtronic device helps in earlier heart failure Family ties play big role in atrial fibrillation HeartWare's implantable heart pump meets study goal Over 60 percent of child deaths in India avoidable: survey StemCells plans chronic spinal cord injury trial November 15, 2010 08:56 AM ET LOS ANGELES (Reuters) - StemCells Inc has filed for Swiss regulatory approval for the first clinical trial of its nerve stem cells in patients with spinal cord injuries as much as a year old, the company said. Full Article Fast heart rate, rhythm problems found in bereaved November 14, 2010 06:10 PM ET CHICAGO (Reuters) - The death of a spouse or child can trigger potentially harmful rapid increases in heart rate and changes in heart-rhythm regularity, but a study showed the measures revert back to normal ranges within six months, researchers said on Sunday. Full Article Less salt for teens means healthier adults November 14, 2010 06:13 PM ET CHICAGO (Reuters) - If teens could reduce their daily salt consumption by 3,000 milligrams, they would cut their risk for heart disease and stroke significantly in adulthood, researchers said on Sunday. Full Article Haiti cholera toll tops 900 with six provinces affected November 14, 2010 06:16 PM ET PORT-AU-PRINCE (Reuters) - The death toll from Haiti's cholera epidemic has reached more than 900 and the disease is present in six of the 10 provinces of the earthquake-battered Caribbean country, the Health Ministry said on Sunday. Full Article Pfizer heart-failure drug helps milder patients: study November 14, 2010 04:28 PM ET CHICAGO (Reuters) - People with mild heart failure lived longer and fared better by adding Pfizer's drug Inspra to standard medications, a finding that could widely expand use of such drugs in healthier patients, researchers said on Sunday. Full Article Bypass patients can benefit from a few drinks: study November 14, 2010 04:51 PM ET CHICAGO (Reuters) - Men who underwent heart bypass surgery and consumed about two drinks a day afterward had fewer subsequent cardiovascular procedures than those who abstained, according to a study released Sunday. Full Article Medtronic device helps in earlier heart failure November 14, 2010 03:11 PM ET CHICAGO (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that shocks the heart if needed, according to new data that support use of the therapy earlier in treatment. Full Article Family ties play big role in atrial fibrillation November 13, 2010 04:04 PM ET CHICAGO (Reuters) - People who have a close family member with atrial fibrillation are 40 percent more likely to develop the heart condition than other people, U.S. researchers said on Saturday. Full Article HeartWare's implantable heart pump meets study goal November 14, 2010 12:37 PM ET CHICAGO (Reuters) - HeartWare International Inc's implantable device heart pump used in patients with advanced heart failure who were awaiting a heart transplant, met its goal in a major study. Full Article Over 60 percent of child deaths in India avoidable: survey November 12, 2010 07:08 PM ET SINGAPORE (Reuters) - More children under the age of five die in India than in any other country in the world, and from five main causes that are avoidable, a study in India has found. Full Article

REUTERS www.reuters.com Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book.Details Subscribe to other Reuters newsletters Unsubscribe from this newsletter. Send this mailing to a friend or colleague Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Interactive TV | Labs | Reuters in Second Life | Archive | Site Index | Video Index Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers